###### Strengths and limitations of this study

-   Approximately 97% of the South Korean population is covered by National Health Insurance Service, and this study effectively uses the claims database to examine and compare medical use and costs of high-frequency shoulder disorders in a nationally representative sample.

-   This study employs national healthcare data to provide a detailed and current perspective of prevalence, medical expenditure and usual care in surgery, injections, physiotherapy and medication use of major shoulder lesions and to provide basic usage data relevant for health policy implementation and budget appropriation.

-   While data are efficiently collected and managed by the Korean Health Insurance Review and Assessment Service through the claims review process, items not covered by National Health Insurance such as over-the-counter drugs and out-of-pocket expenditures could not be assessed.

-   In addition, due to the fact that analysis was performed based on administrative codes of frequent shoulder disorders as opposed to clinical conditions or symptoms, the possibility of mismatched coding cannot be ruled out.

-   Still, the authors attempted to enhance internal validity by collecting data from patients with X-ray results.

Introduction {#s1}
============

Shoulder pain is commonly seen in primary healthcare and incurs significant pain and disability, healthcare costs and work loss.[@R1] The annual prevalence and incidence of patients with shoulder disorder in UK primary care were 2.36% and 1.47%, respectively,[@R2] and its annual prevalence in Dutch primary care was estimated to be about 11 per 1000 patients.[@R3] A 2004 systematic review reported point prevalence of 6.9%--26% and lifetime prevalence of 6.7%--66.7% with higher estimates gauged from older study populations (65+ years).[@R4] Meanwhile, 2011 Korean National Health Insurance Service statistics showed that a total 4.3% of the Korean population was diagnosed with shoulder pain (Korean Standard Classification of Diseases (KCD) diagnosis code M75) with an average annual increase of 8.9% over the past 6 years, indicating that the importance of shoulder pain diagnosis and treatment is growing in primary and national healthcare settings.[@R5]

Shoulder pain is the third most common cause of primary care consultation in musculoskeletal conditions, and approximately 1% of UK adults annually consult a general practitioner for new shoulder pain according to a 1998 population survey of 6000 UK clinic patients.[@R6] Annual prevalence estimates of shoulder pain and medical consultations in Australian general practice have also been put at 1%--1.5%.[@R7] While chronic shoulder pain is a common manifestation, its pathogenesis is often diverse and complex, incurring substantial medical costs in diagnosis and treatment, and shoulder problems are a significant cause of morbidity and disability in the general population.[@R8] In 1995 alone, musculoskeletal disorders accounted for 9.9 million days of sick leaves in the UK of which 4.2 million (42%) were related to the upper limb and neck area,[@R9] showing that musculoskeletal complaints place a heavy burden on primary care services in general[@R2] and that the economic burden of upper limb disorders is substantial.[@R8] Direct medical expenses for shoulder disability reached US\$7 billion in the USA in 2000.[@R10] Similarly, in Korea, 1 954 642 patients were diagnosed with shoulder disorders (KCD, sixth revision (KCD-6) diagnosis code M75) with an annual health expenditure of approximately US\$39.8 million according to the 2014 National Health Insurance Statistical Yearbook.[@R11]

Chronic shoulder pain has been linked with various pathologies ranging from bursitis, tendinitis, rotator cuff tear, adhesive capsulitis, impingement syndrome, avascular necrosis and glenohumeral osteoarthritis (OA) to joint degeneration and injury, which can occur either singularly or in combination. Rotator cuff injury and adhesive capsulitis hold high prevalence of chronic disorders, comprising 10% and 6% of all shoulder-related disorders, respectively.[@R10] Shoulder impingement syndrome is also common with 5 out of 1000 individuals annually diagnosed as new clinical cases.[@R3] However, disproportionate to the high prevalence and associated costs of adhesive capsulitis, rotator cuff syndrome and shoulder impingement syndrome, comprehensive studies detailing specific components of usual care and related medical expenses have been found lacking.

The Korean healthcare system is implemented under the National Health Insurance programme, which enforces legal obligation and authority as a universal social insurance programme covering approximately 97% of the South Korean population. The National Health Insurance Service (NHIS) operates the healthcare system under government supervision and promotes public health by providing basic healthcare services.[@R12] This study aimed to assess the prevalence, associated healthcare use and related costs of common shoulder disorders in Korea through analysis of National Health Insurance claims data provided by the Health Insurance Review and Assessment Service (HIRA), which reviews and assesses all NHIS claims data. This dataset includes nationally representative data of 1.4 million patients, covering approximately 3% of 47 million Koreans covered by National Health Insurance out of the total South Korean population (51 million).

Methods {#s2}
=======

Participants {#s2a}
------------

The 2014 National Patient Sample (NPS) dataset analysed in this study was provided by HIRA. Details on specific medical services and prescription history for the past year, as well as the demographic characteristics from a 3% sample randomly extracted after stratification by age (in 5-year intervals) and sex, are provided by HIRA on an annual basis for the aim of enhancing data accessibility and convenience of researchers. This secondary dataset is systematically sampled through stratification after removing identifying personal and institutional information from the raw claims data of all provided medical services compiled from all patients with medical service use for the past year as of the medical care commencement date of the corresponding year. The NPS sample dataset contains information on approximately 1.4 million patients.[@R13]

Shoulder disorders {#s2b}
------------------

Data were collected from all patients who were diagnosed with subcategory codes M75 (collective referral to all subcategory codes under basic KCD-6 code 'M75,' for shoulder disorders) as the primary diagnosis and had shoulder X-ray results taken within the corresponding year. Adhesive capsulitis of the shoulder (ACS; KCD-6 code M750), rotator cuff tear or rupture (RCS; KCD-6 code M751) and shoulder impingement syndrome (SIS; KCD-6 code M754) were included as the major categories of shoulder disorders based on prevalence. A total of 10 336, 9387 and 7135 outpatients and 464, 1432 and 695 inpatients were diagnosed with ACS (total n=10 447), RCS (total n=9689) and SIS (total n=7328), respectively. The total number of patients in each subset may be smaller than the numerical sum of corresponding inpatients and outpatients as some patients received both ambulatory and hospitalised care, and tallies allowed for duplicates. All shoulder-related diagnostic codes and numbers of patients are summarised in online [supplementary table S1](#SP1){ref-type="supplementary-material"}.
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Analysis {#s2c}
--------

Sociodemographic characteristics of patients investigated in this study included age, sex, insurance eligibility, type of medical institution visited for medical service and specialty of consulting physicians. Medical institutions were classified into primary care clinics, hospitals, general hospitals, tertiary hospitals, long-term care hospitals and public health centres. Hospitals hold ≥30 inpatient beds, while general hospitals operate ≥300 beds for inpatient care and at least three outpatient departments out of internal medicine, surgery, paediatrics, and obstetrics and gynaecology with corresponding full-time specialists. Tertiary hospitals provide specialised, advanced medical care for serious medical disorders out of general hospitals with ≥20 departments designated by order of the Korean Ministry of Health and Welfare with corresponding full-time specialists for each specialty.[@R14]

Medical service costs covering costs for visit (consultation), hospitalisation, medication, injection, anaesthesia, physiotherapy, psychotherapy, procedure/surgery, examination and radiologic evaluation/intervention were calculated from corresponding codes as designated according to Ministry of Health and Welfare notification. Total medical expense was determined as the sum of co-payment paid by the patient and insurance benefit covered by the National Health Insurance, of which the benefit amount is determined through HIRA review. Frequency of medical service use, including surgery, injection, physiotherapy and analgesics, was investigated in inpatients and outpatients separately and totalled for each diagnosis category. The codes for surgery, injection and physiotherapy are given in online [supplementary table S2](#SP1){ref-type="supplementary-material"}, and detailed information on each code is available online as a guidebook in PDF format from the HIRA website.[@R15] Only service codes that were verified to be relevant to shoulder disorders were analysed. Physiotherapy and rehabilitation therapy types prescribed to at least 500 cases were assessed for frequency. Drugs prescribed in inpatient or outpatient departments were classified according to Anatomical Therapeutic Chemical (ATC) Classification System fourth-level classifications and were organised in order of usage proportion by non-narcotic and narcotic categories. The non-narcotic and narcotic drug classifications were adopted from analgesics categories in a previous report from the Korean National Evidence-based Healthcare Collaborating Agency.[@R16] Although most drug substance names are identical with ATC fifth-level classifications, which indicate chemical names, a few exceptions do not have matching classifications. A drug was considered to be prescribed following medication code records, regardless of dose.

Statistical analysis {#s2d}
--------------------

All statistical analyses were performed using SAS version 9.3 (SAS Institute, Cary, North Carolina, USA). The sociodemographic characteristics and medical services provided to inpatients and outpatients were analysed through frequency analysis for each shoulder disorder category. Descriptive analysis results are presented as frequencies and percentages. Percentages were calculated with total number of patients or total expense in the corresponding disease group set as the denominator. Total expense and per-patient expenses for each disease group were also calculated.

Ethics statement {#s2e}
----------------

This study was reviewed and approved by the Institutional Review Board of Jaseng Hospital of Korean Medicine (JASENG 2016-11-002).

Results {#s3}
=======

Medical service use for ACS, RCS and SIS {#s3a}
----------------------------------------

While the ACS group contained the highest total number of patients (n=10 447), total expense, per-patient expense, average days of care and average numbers of visits were highest in the RCS group. Outpatient values were highest in the ACS group, followed by RCS and SIS groups in number of patients, total expense, per-patient expense, average days of care and average numbers of visits, while inpatient values were highest in the RCS group, followed by the SIS and ACS groups. Total medical expenditure was 56.84% in inpatients (9.43%) compared with 43.16% in outpatients (90.57%), even though the majority of patients were outpatients ([table 1](#T1){ref-type="table"}).

###### 

General medical service use for adhesive capsulitis of the shoulder, rotator cuff syndrome and shoulder impingement syndrome in Korea

  ------------------------------------------------------------------------------------------------------------------------------------
  Visit type   Disorder groups   Patients (n)     **Total expense**\*   **Per-patient expense**\*   Days of treatment†   Visits (n)‡
  ------------ ----------------- ---------------- --------------------- --------------------------- -------------------- -------------
  Total        ACS               10 447           1 817 540 220\        173 977.2\                  6.3                  5.7
                                                  (1 588 758.9)         (152.1)                                          

  RCS          9689              4 147 531 010\   428 066.0\            8.4                         6.1                  
                                 (3 625 464.2)    (374.2)                                                                

  SIS          7328              1 621 638 960\   221 293.5\            5.8                         4.6                  
                                 (1 417 516.6)    (193.4)                                                                

  Outpatient   ACS               10 336           1 415 669 040\        136 964.9\                  5.7                  5.4
                                                  (1 237 472.9)         (119.7)                                          

  RCS          9387              1 144 119 540\   121 883.4\            5.4                         4.7                  
                                 (1 000 104.5)    (106.5)                                                                

  SIS          7135              714 434 250\     100 130.9\            4.2                         3.9                  
                                 (624 505.5)      (87.5)                                                                 

  Inpatient    ACS               464              401 871 180\          866 101.7\                  15.2                 6.6
                                                  (351 286.0)           (757.1)                                          

  RCS          1432              3 003 411 470\   2 097 354.4\          21.4                        10.7                 
                                 (2 625 359.7)    (1833.4)                                                               

  SIS          695               907 204 710\     1 305 330.5\          17.5                        8.5                  
                                 (793 011.1)      (1141.0)                                                               
  ------------------------------------------------------------------------------------------------------------------------------------

\*Displayed in KRW; US\$1=1144 KRW (as of October 31, 2016); approximate US\$ equivalents are given beneath in parentheses.

†Total days of treatment per patient as indicated in the claims statement, which includes drug prescription days without medical treatment.

‡Total number of visits or number of hospitalised days per patient as indicated in the claims statement.

ACS, adhesive capsulitis of the shoulder; RCS, rotator cuff syndrome; SIS, shoulder impingement syndrome.

Characteristics of ACS, RCS and SIS patients {#s3b}
--------------------------------------------

The prevalence of ACS, RCS and SIS was highest among patients in their 50s, and women were more likely to be affected than men. About 97% of all patients received medical care in the ambulatory department and 96% were National Health Insurance-eligible. The most frequently visited medical institution types were primary care clinics, followed by hospitals and general hospitals. The proportion of visits to primary care clinics in ACS cases was 75.80%, which was higher than in the other diagnosis groups (56.99% in RCS and 48.06% in SIS, respectively). Patients were treated by orthopaedic surgeons in 80%--90% of all cases regardless of shoulder disorder type ([table 2](#T2){ref-type="table"}).

###### 

Sociodemographic characteristics of adhesive capsulitis of patients with shoulder, rotator cuff syndrome and shoulder impingement syndrome

  Characteristics              ACS      RCS     SIS    Total sample population                              
  ---------------------------- -------- ------- ------ ------------------------- ------ ------- ----------- -------
  Age (years)                                                                                               
   \<20                        21       0.20    80     0.83                      70     0.96    313 646     21.81
   20\~29                      91       0.87    263    2.71                      278    3.79    180 111     12.52
   30\~39                      337      3.23    679    7.01                      662    9.03    217 735     15.14
   40\~49                      1838     17.59   1925   19.87                     1731   23.62   242 157     16.84
   50\~59                      3761     36.00   3186   32.88                     2508   34.22   228 492     15.89
   60\~69                      2465     23.60   2160   22.29                     1304   17.79   131 499     9.14
   ≥70                         1934     18.51   1396   14.41                     775    10.58   124 538     8.66
  Sex                                                                                                       
   Male                        4178     39.99   4348   44.88                     3471   47.37   699 035     48.61
   Female                      6269     60.01   5341   55.12                     3857   52.63   739 143     51.39
  Visit type                                                                                                
   Inpatient                   464      4.44    1432   14.78                     695    9.48    193 184     13.43
   Outpatient                  10 336   98.94   9387   96.88                     7135   97.37   1 433 858   99.70
  Insurance type                                                                                            
   National Health Insurance   9984     95.57   9336   96.36                     7092   96.78   1 398 282   97.23
   Medicaid                    470      4.50    356    3.67                      235    3.21    44 652      3.11
   Veteran healthcare          9        0.09    32     0.33                      18     0.25    3260        0.23
  Medical institution                                                                                       
   Clinic                      7919     75.80   5522   56.99                     3522   48.06   1 316 958   91.57
   Hospital                    2243     21.47   2786   28.75                     3020   41.21   406 611     28.27
   General hospital            741      7.09    1473   15.20                     945    12.90   375 571     26.11
   Tertiary hospital           138      1.32    648    6.69                      157    2.14    207 937     14.46
   Long-term care hospital     87       0.83    31     0.32                      21     0.29    27 437      1.91
   Public health centre        41       0.39    18     0.19                      4      0.05    81 007      5.63
  Medical specialty                                                                                         
   Orthopaedic surgery         8762     83.87   8670   89.48                     6737   91.94   584 569     40.65
   Anaesthesiology             750      7.18    560    5.78                      334    4.56    58 270      4.05
   Neurosurgery                490      4.69    261    2.69                      142    1.94    107 990     7.51
   Rehabilitation medicine     483      4.62    374    3.86                      181    2.47    33 104      2.30
   General surgery             352      3.37    100    1.03                      65     0.89    222 058     15.44
   Internal medicine           240      2.30    81     0.84                      42     0.57    966 320     67.19
   Family medicine             192      1.84    73     0.75                      53     0.72    152 569     10.61
   Other\*                     95       0.91    24     0.25                      13     0.18    875 225     60.86
   General physician           33       0.32    9      0.09                      1      0.01    82 475      5.73

\*Includes neurology, radiology, emergency medicine, occupational and environmental medicine, neuropsychiatry, paediatrics, thoracic and cardiovascular surgery, obstetrics and gynaecology, and urology.

ACS, adhesive capsulitis of the shoulder; RCS, rotator cuff syndrome; SIS, shoulder impingement syndrome.

Distribution of ACS, RCS and SIS-related costs {#s3c}
----------------------------------------------

All medical expenses were assessed according to the type of medical service provided (ie, visit (consultation), hospitalisation, injection, anaesthesia, physiotherapy, psychotherapy, procedure/surgery, examination and radiologic evaluation/intervention). Costs of visit (consultation), anaesthesia and physiotherapy took up a significant portion of ACS costs, whereas costs of procedure/surgery, hospitalisation and visits (consultations) were dominant for patients with RCS, and costs of procedure/surgery, visits (consultations) and hospitalisation for patients with SIS. The sum of costs for procedure/surgery and hospitalisation were 53.17% and 37.24% of total expenses for patients with RCS and SIS, respectively, while the sum was low at 6.46% in patients with ACS. In contrast, the cost of injections was higher accounting for 11.46% of the total expense in patients with ACS, compared with those of 6.94% and 8.60% in patients with RCS and SIS, respectively. More than 10% of all patients were prescribed drugs, but the cost of medication amounted to less than 2% of total medical expense in all three groups. Percentages of physiotherapy cost out of total medical expense were 61.79%, 53.72% and 52.46% in the ACS, RCS and SIS groups, respectively, and more than half of all patients received physiotherapy in each disease category. The cost of radiologic evaluation/intervention totalled to less than 10% of total expense, and the proportion of injection use was higher than that of drug prescription for all the three groups ([table 3](#T3){ref-type="table"}).

###### 

Distribution of medical expenses in adhesive capsulitis of the shoulder, rotator cuff syndrome and shoulder impingement syndrome

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Classification                         ACS      RCS     SIS                                                                                                                          
  -------------------------------------- -------- ------- -------------- ------- ---------- ------ ------- ---------------- ------- ------------ ------ ------- -------------- ------- ----------
  Procedure/surgery                      675      6.46    136 465 846\   7.47    202 172\   1413   14.58   1 564 836 881\   37.77   1 107 457\   682    9.31    377 063 209\   23.22   552 879\
                                                          (119 288.3)            (176.7)                   (1 367 864.4)            (968.1)                     (329 600.7)            (483.3)

  Hospitalisation                        455      4.36    114 823 033\   6.29    252 358\   1430   14.76   638 096 201\     15.40   446 221\     693    9.46    227 699 184\   14.02   328 570\
                                                          (100 369.8)            (220.6)                   (557 776.4)              (390.1)                     (199 037.7)            (287.2)

  Visit (consultation)                   10 440   99.93   589 812 205\   32.30   56 495\    9675   99.86   478 580 607\     11.55   49 466\      7323   99.93   306 608 403\   18.88   41 869\
                                                          (515 570.1)            (49.4)                    (418 339.7)              (43.2)                      (268 014.3)            (36.6)

  Anaesthesia                            3403     32.57   255 121 953\   13.97   74 970\    3285   33.90   377 973 595\     9.12    115 060\     1885   25.72   156 638 479\   9.65    83 097\
                                                          (223 008.7)            (65.5)                    (330 396.5)              (100.6)                     (136 921.7)            (72.6)

  Injection                              7282     69.70   209 291 146\   11.46   28 741\    5794   59.80   287 469 148\     6.94    49 615\      4159   56.75   139 571 789\   8.60    33 559\
                                                          (182 946.8)            (25.1)                    (251 284.2)              (43.4)                      (122 003.3)            (29.3)

  Examination                            1287     12.32   67 690 217\    3.71    52 595\    2112   21.80   254 326 395\     6.14    1 20 420\    1210   16.51   112 296 357\   6.92    92 807\
                                                          (59 169.8)             (46.0)                    (222 313.3)              (105.3)                     (98 161.2)             (81.1)

  Radiographic evaluation/intervention   9051     86.64   184 672 970\   10.11   20 404\    8745   90.26   233 913 993\     5.65    26 748\      6632   90.50   150 304 187\   9.26    22 663\
                                                          (161 427.4)            (17.8)                    (204 470.3)              (23.4)                      (131 384.8)            (19.8)

  Physiotherapy                          6455     61.79   248 881 906\   13.63   38 556\    5205   53.72   230 160 138\     5.56    44 219\      3844   52.46   124 154 140\   7.65    32 298\
                                                          (217 554.1)            (33.7)                    (201 188.9)              (38.7)                      (108 526.3)            (28.2)

  Medication                             1123     10.75   19 056 208\    1.04    16 969\    1805   18.63   77 297 308\      1.87    42 824\      931    12.70   29 484 743\    1.82    31 670\
                                                          (16 657.5)             (14.8)                    (67 567.6)               (37.4)                      (25 773.4)             (27.7)

  Psychotherapy                          --       --      --             --      --         7      0.07    158 388\         0.00    22 626.9\    --     --      --             --      --
                                                                                                           (138.5)                  (19.8)                                             
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Displayed in KRW; US\$1=1144 KRW (as of October 31^st^, 2016); approximate US\$ equivalents are given beneath in parentheses.

ACS, adhesive capsulitis of the shoulder; RCS, rotator cuff syndrome; SIS, shoulder impingement syndrome.

Usual care for ACS, RCS and SIS {#s3d}
-------------------------------

The percentage of surgically treated cases was highest in the RCS group and lowest in the ACS group. The most frequently performed surgery for shoulder disorders was acromioplasty. The proportion of subcutaneous or intramuscular and intra-articular injections in outpatients was comparable in all three groups, ranging from 20% to 30%, although the proportion was slightly higher in the ACS group. In order of decreasing frequency, superficial heat therapy, deep heat therapy, transcutaneous electrical nerve stimulation and interferential current therapy were the most commonly used physiotherapy modalities, and overall prescription proportion of physiotherapies was highest in the ACS group, followed by the RCS and SIS groups. Heat therapies including superficial and deep heat therapies were prescribed to about half of all shoulder cases. The proportions of transcutaneous electrical nerve stimulation and interferential current therapy ranged from 20% to 30% in all three groups. Meanwhile, the prescription proportion of laser therapy was less than 10%.

Simple therapeutic exercise was prescribed to 19.04% of patients with ACS, which was more than twice that of the RCS and SIS groups; however, complex therapeutic exercise was prescribed more often in the RCS group (7.05%) than in the ACS (2.90%) or SIS (4.49%) groups. Other physiotherapies were less frequently prescribed, but it is worth noting that the proportion of complex therapeutic exercise was significantly higher in inpatients than in outpatients at 23.06%, 27.58% and 29.78% in the ACS, RCS and SIS groups, respectively. Myofascial trigger point injection therapy was seldom used in both inpatients and outpatients ([table 4](#T4){ref-type="table"}).

###### 

Usual care of adhesive capsulitis of the shoulder, rotator cuff syndrome and shoulder impingement syndrome, excluding medication

                                                 Subtype                                                      Total   Inpatient   Outpatient                                                                                                                   
  ---------------------------------------------- ------------------------------------------------------------ ------- ----------- ------------ ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  Surgery                                        Acromioplasty and repair of ruptured shoulder rotator cuff   20      0.19        849          8.76    101     1.38    20      4.31    848     59.22   101     14.53   --      --      1       0.01    --      --
  Acromioplasty                                  94                                                           0.90    172         1.78         283     3.86    94      20.26   171     11.94   283     40.72   --      --      1       0.01    --      --      
  Replacement arthroplasty--Total arthroplasty   1                                                            0.01    18          0.19         0       0.00    1       0.22    18      1.26    0       0.00    --      --      --      --      --      --      
  Injection                                      Subcutaneous or intramuscular injection                      3608    34.54       3135         32.36   2014    27.48   271     58.41   1037    72.42   463     66.62   3398    32.88   2256    24.03   1623    22.75
  Intra-articular injection                      3103                                                         29.70   1790        18.47        1630    22.24   141     30.39   143     9.99    115     16.55   3017    29.19   1677    17.87   1551    21.74   
  Physiotherapy                                  Superficial heat therapy                                     6610    63.27       5147         53.12   3698    50.46   319     68.75   657     45.88   372     53.53   6396    61.88   4696    50.03   3428    48.04
  Deep heat therapy                              5564                                                         53.26   4222        43.58        3208    43.78   174     37.50   377     26.33   243     34.96   5461    52.83   4008    42.70   3057    42.85   
  Interferential current therapy                 3286                                                         31.45   2450        25.29        1924    26.26   149     32.11   249     17.39   166     23.88   3188    30.84   2305    24.56   1807    25.33   
  Transcutaneous electrical nerve stimulation    2962                                                         28.35   2172        22.42        1484    20.25   84      18.10   289     20.18   137     19.71   2906    28.12   1994    21.24   1388    19.45   
  Simple therapeutic exercise\*                  1989                                                         19.04   855         8.82         642     8.76    94      20.26   145     10.13   156     22.45   1920    18.58   773     8.23    523     7.33    
  Laser therapy\*                                786                                                          7.52    841         8.68         557     7.60    33      7.11    169     11.80   100     14.39   763     7.38    719     7.66    479     6.71    
  Complex therapeutic exercise\*                 303                                                          2.90    683         7.05         329     4.49    107     23.06   395     27.58   207     29.78   243     2.35    476     5.07    179     2.51    
  Myofascial trigger point injection therapy†    285                                                          2.73    264         2.72         215     2.93    10      2.16    21      1.47    21      3.02    276     2.67    245     2.61    196     2.75    
  Therapeutic exercise, isokinetic\*             3                                                            0.03    8           0.08         1       0.01    1       0.22    4       0.28    1       0.14    3       0.03    7       0.07    1       0.01    

\*Simple rehabilitation treatments, which can be prescribed by rehabilitation medicine, orthopaedic surgery, neurosurgery, neurology, general surgery, cardiovascular surgery and anaesthesiology specialists.

†Complex rehabilitation treatment, which can only be prescribed by rehabilitation medicine specialists.

ACS, adhesive capsulitis of the shoulder; RCS, rotator cuff syndrome; SIS, shoulder impingement syndrome.

Medication use in ACS, RCS and SIS {#s3e}
----------------------------------

The drugs prescribed in shoulder disorders were classified according to the ATC fourth level. The absolute majority of drug prescriptions were non-narcotic (n=35 021/36 638; 95.38%), and narcotic analgesics, when used, were mainly prescribed in hospital settings (n=1505/1617; 93.07%). Among non-narcotic drugs, acetic acid derivatives and related substances, other opioids, propionic acid derivatives, other anti-inflammatory and anti-rheumatic agents (non-steroids), oxicams and anilide groups were frequently prescribed (listed in order of frequency). Tramadol was the only drug prescribed from the other opioids group. Of narcotic drugs, opioid anaesthetics, phenylpiperidine derivatives and natural opium alkaloids were commonly prescribed (listed in order of frequency) ([table 5](#T5){ref-type="table"}). Prescription details in accordance with fifth-level ACT codes are summarised in online [supplementary table S3](#SP1){ref-type="supplementary-material"}.

###### 

Medication prescribed for adhesive capsulitis of the shoulder, rotator cuff syndrome and shoulder impingement syndrome as assessed at the fourth ATC level

  ATC code                                                                  Total   Inpatient   Outpatient                                                                                                          
  ----------------------------------------------------------------- ------- ------- ----------- ------------ ------- ------ ------- ----- ------- ------ ------- ----- ------- ------ ------- ------ ------- ------ -------
  Non-narcotics                                                                                                                                                                                                     
   Acetic acid derivatives and related substances                   M01AB   4515    43.22       4053         41.83   2751   37.54   299   64.44   1027   71.72   465   66.91   4353   42.11   3481   37.08   2602   36.47
   Other opioids\*                                                  N02AX   2881    27.58       2273         23.46   1585   21.63   145   31.25   637    44.48   262   37.70   2768   26.78   1820   19.39   1434   20.10
   Propionic acid derivatives                                       M01AE   2336    22.36       1800         18.58   1316   17.96   62    13.36   235    16.41   149   21.44   2294   22.19   1646   17.53   1218   17.07
   Other anti-inflammatory and antirheumatic agents, non-steroids   M01AX   1708    16.35       1291         13.32   961    13.11   63    13.58   204    14.25   87    12.52   1665   16.11   1143   12.18   907    12.71
   Oxicams                                                          M01AC   1032    9.88        980          10.11   676    9.22    73    15.73   181    12.64   78    11.22   978    9.46    871    9.28    634    8.89
   Anilides                                                         N02BE   780     7.47        893          9.22    428    5.84    50    10.78   297    20.74   92    13.24   738    7.14    624    6.65    348    4.88
   Other general anaesthetics                                       N01AX   104     1.00        607          6.26    221    3.02    99    21.34   607    42.39   220   31.65   5      0.05    --     --      1      0.01
   Other centrally acting agents                                    M03BX   369     3.53        273          2.82    209    2.85    4     0.86    15     1.05    12    1.73    367    3.55    259    2.76    197    2.76
   Cyclo-oxygenase-2 inhibitors                                     M01AH   172     1.65        464          4.79    168    2.29    7     1.51    110    7.68    8     1.15    168    1.63    401    4.27    164    2.30
   Fenamates                                                        M01AG   30      0.29        25           0.26    9      0.12    1     0.22    8      0.56    3     0.43    29     0.28    17     0.18    7      0.10
   Morphinan derivatives                                            N02AF   2       0.02        18           0.19    14     0.19    1     0.22    18     1.26    14    2.01    1      0.01    --     --      --     --
   Barbiturates, plain                                              N01AF   --      --          30           0.31    1      0.01    --    --      30     2.09    1     0.14    --     --      --     --      --     --
   Other nervous system drugs                                       N07XX   4       0.04        9            0.09    8      0.11    3     0.65    9      0.63    3     0.43    1      0.01    --     --      5      0.07
   Glucocorticoids                                                  H02AB   5       0.05        5            0.05    4      0.05    1     0.22    --     --      1     0.14    4      0.04    5      0.05    3      0.04
   Salicylic acid and derivatives                                   N02BA   2       0.02        7            0.07    2      0.03    --    --      4      0.28    2     0.29    2      0.02    3      0.03    --     --
  Narcotics                                                                                                                                                                                                         
   Opioid anaesthetics                                              N01AH   72      0.69        614          6.34    147    2.01    72    15.52   612    42.74   147   21.15   --     --      2      0.02    --     --
   Phenylpiperidine derivatives                                     N02AB   43      0.41        299          3.09    67     0.91    37    7.97    299    20.88   67    9.64    7      0.07    --     --      --     --
   Natural opium alkaloids                                          N02AA   66      0.63        231          2.38    63     0.86    34    7.33    191    13.34   37    5.32    35     0.34    57     0.61    29     0.41
   Opium alkaloids and derivatives                                  R05DA   2       0.02        8            0.08    5      0.07    --    --      5      0.35    4     0.58    2      0.02    7      0.07    1      0.01

\*Although labelled 'other opioids', fourth ATC level other opioids include both narcotics and non-narcotics. No drugs other than tramadol were prescribed.

ACS, adhesive capsulitis of the shoulder; ATC, anatomical therapeutic chemical; RCS, rotator cuff syndrome; SIS, shoulder impingement syndrome.

Discussion {#s4}
==========

The prevalence and medical service use of high-prevalence shoulder disorders in Korea were investigated based on 2014 HIRA-NPS data, and treatment types and related costs were further analysed. In all three groups, the outpatient proportion was higher. Shoulder disorders were most prevalent in middle-aged populations. ACS cases were more often treated in primary care settings than RCS and SIS, but a high percentage of patients sought medical care from orthopaedic surgeons in all three groups, displaying marked specialty preference. The cost for visits (consultations) was largest in total medical expenses for the ACS and SIS groups, while cost for procedure/surgery was the predominant factor for patients with RCS. In all three groups, injection usage proportions were higher than those for drug prescription with a slightly higher injection percentage in patients with ACS. In physiotherapies, superficial heat therapy, deep heat therapy, transcutaneous electrical nerve stimulation and interferential current therapy were commonly used. Acetic acid derivatives and related substances were the most frequently prescribed non-narcotic analgesics out of fourth ATC levels, and opioid anaesthetics were the most frequently prescribed narcotics.

In a previous study on prevalence of shoulder disorders,[@R4] supraspinatus tendinitis was the most common shoulder joint condition found in adults aged ≥40 years, and prevalence of rotator cuff tear without trauma and adhesive capsulitis increased steeply with age, which is consistent with current study findings. Also, a number of studies have reported gender difference in prevalence of shoulder disorders,[@R2] and suggested explanations include hypotheses that women are more exposed to musculoskeletal risk factors in the form of various biological, sociological and psychological factors (eg, repetitive housework, lower accessibility to medical services and variance in sensory pain).[@R6]

Medical expenses were higher in inpatients than in outpatients for all three shoulder disorders, which is suggestive of sizeable economic burden from surgery. Total per-patient medical expenses were particularly high in the RCS group at twice the amount of the other two groups and may partially be explained by the high number of inpatients and surgically treated cases in this group. In light of these findings, medical policies pertaining to RCS should focus on hospitalisation in order to effectively address its socioeconomic cost.

Steady increase in surgical interventions for rotator cuff injury has been reported in the USA,[@R21] UK,[@R24] Denmark[@R25] and Finland[@R26] in recent decades but has also been implicated with escalating medical expenditure.[@R27] A 2008 Cochrane review failed to find conclusive evidence supporting surgical approaches for rotator cuff injuries, citing three independent trials reporting that therapeutic benefit of intensive rehabilitation programs were comparable to arthroscopic or subacromial decompression surgeries.[@R29] In light of these results, coupled with the significant costs of surgery, surgical interventions should be considered when definite indications are clearly present.[@R30]

Notably, usage proportions of injection exceeded those of drug prescription in all three groups. Glenohumeral corticosteroid injection without guide imaging was previously shown to be more effective than oral non-steroidal anti-inflammatory drugs, and injections have been advocated over oral medicine with corticosteroids recommended for management of adhesive capsulitis on the grounds of fewer complications and adverse effects.[@R31]

X-rays are regularly performed for diagnosis of most musculoskeletal conditions in Korea, including those of the shoulder joint. Shoulder radiographic findings are of particular use in OA, calcification (with sudden increase of pain), subacromial spurs (in clinically significant impingement), humeral head elevation and narrowing of the subacromial space.[@R32]

This study results show that heat and electrical therapies were the most popular physiotherapies for shoulder disorders in Korea. Previous studies report that the evidence for the effect of electrical therapies in treatment of such disorders as subacromial impingement syndrome or rotator cuff tendinitis is unclear when compared with placebo.[@R33] Although the treatment failed to accelerate recovery, it is assumed that it continues to be widely used in clinical settings because of its temporary pain-relieving effects and low adverse event occurrence. These findings are comparable and compatible with National Health Insurance claims data low back pain (LBP) analysis results where heat and electrical therapies were consistently used at similar frequencies and distribution regardless of LBP type.[@R35] It can be inferred that heat and electrical therapies are widely used as usual care of various musculoskeletal diseases relating to shoulder pain and LBP in Korea despite lack of supporting evidence. Simple therapeutic exercise tended to be prescribed more often in patients with ACS (19.04%) than in patients with RCS (8.82%) or patients with SIS (8.76%). Griggs *et al* [@R36] reported in a prospective study of four shoulder stretching exercise regimens in 75 patients with phase II shoulder impingement that exercise led to improved pain, range of motion (ROM) and functionality as measured by Disabilities of the Arm, Shoulder, and Hand in 90% of cases. Dierks *et al* also proposed gentle exercises that do not cause or exacerbate pain improve shoulder ROM.[@R37]

In Korea, certain types of physiotherapy and exercise therapy can only be prescribed by rehabilitation medicine specialists. For example, laser therapy and therapeutic exercise are classified as simple rehabilitation therapy, while myofascial trigger point injection therapy is considered complex rehabilitation therapy as it is perceived to require more specific medical attention. The low prescription proportion of myofascial trigger point injection therapy, laser therapy and therapeutic exercise may be partially explained by the fact that prescription is exclusively available to select specialists.

Ninety-seven per cent of all Koreans are enrolled in National Health Insurance, and claims data are widely accepted to be representative of the Korean population at a national level. The NPS dataset, managed and maintained by HIRA, contains detailed information on diagnosis, medical history, insurance payment and patient demographics. The current study employed HIRA-NPS data to investigate current medical usage, usual care and related expenditure in management of major shoulder disorders in Korea. As the HIRA-NPS data were extracted as a 3% sample of total claims data, number of patients and cost estimations for the total population may be gauged through multiplication by the weight value of 33.3. The present findings on medical care and costs for high prevalence shoulder conditions may be of use to physicians in building a basic structured foundation for standardised care.

The data analysed in the current study were based on nationwide medical institution diagnosis codes classified by Statistics Korea, which may lack precision in exclusively selecting shoulder symptom patients. In an attempt to overcome such limitations, only data for main diagnosis of shoulder disorders were collected, excluding subdiagnosis of shoulder lesions. However, such arbitrary exclusion of subdiagnosis groups may diminish overall representativeness of findings. Also, due to the fact that analysis was performed using administrative codes, and not actual clinical conditions or symptoms, the possibility of mismatched coding cannot be ruled out. Although clear diagnostic criteria exist in primary care for shoulder pain, SIS, supraspinatus tendonitis, biceps tendonitis and ACS,[@R38] difference arising from such factors as individual preference, working policies, proficiency and errors must be taken into account in data conformity. Park *et al* purported that diagnosis processes tended to be more accurate in hospitalised or severe patients than in ambulatory or mild cases and in tertiary hospitals compared with primary care clinics.[@R39] As the main objective of this study was to assess the current status of medical service use and usual care in patients with a main complaint of shoulder disorders, the inclusion criteria were initially set as patients with a primary diagnostic code for shoulder disorders of KCD codes. However, there was expert opinion that KCD codes are primarily an administrative coding system and that primary and secondary diagnosis KCD codes may not be clearly differentiated under current Korean healthcare conditions. Shoulder region X-ray results were included as inclusion criteria to improve precision in patient identification as X-rays are routinely conducted in clinical practice in Korea to heighten accuracy in shoulder pathology diagnosis and treatment. This selection method is in line with the inclusion of lumbar X-rays in defining patients with chronic LBP in a report using the same data source as the current study, issued by the National Evidence-based Healthcare Collaborating Agency, a government-run research entity.[@R16] However, although the aim was to improve precision in identification of main diagnosis of shoulder disorders by including shoulder region X-rays, this also leads to exclusion of patients with shoulder disorder without X-ray results, which may be considered an additional limitation of this study.

Intrinsic limitations regarding current data exist in that information on individual patient income, educational levels, residential areas, serological findings, smoking status and drinking habits are lacking, which limits further investigation for causal relationships. Also, details on medical services including surgery, injection, physiotherapy, medication and other data that were clearly non-associated with shoulder disorders were discarded in the process of data identification and selection. However, whether the medical services included for analysis were exclusively provided for shoulder disorders could not be verified.

Finally, the HIRA-NPS dataset only includes data on items covered by National Health Insurance, and medical treatments or medications that are not covered by national insurance and drugs or supplements that are sold over-the-counter could therefore not be included in the present analysis, limiting appreciation of the full spectrum of usual care for shoulder disorder management in Korea.

The study results may be considered to hold significance largely in the following aspects: analysis of prevalence, patient characteristics, medical expenditure and specific medical service use of high-frequency shoulder disorders in Korea from nationally representative data sources may be used in establishing healthcare policies, appropriating budgets for shoulder disorders and providing general guidelines for high-frequency treatments (usual care) and related medical expenses of high-prevalence shoulder disorders---including medication use---to practitioners. Also, from a research standpoint, these findings act as a basic guide in clinical study design as pragmatic studies on shoulder disorders often set standard care or usual care as the control. The results further offer a window into current usual care for shoulder disorders in clinical settings from a healthcare data source representative of Korea, allowing comparisons to be drawn and thus holding international implications for clinicians, researchers and healthcare policy makers.

Conclusion {#s5}
==========

The prevalence, medical service use and usual care employed for shoulder disorder management in Korea were investigated through analysis of National Health Insurance claims data, as extracted and provided by HIRA. As observational studies on healthcare use in patients with shoulder disorder at a national level have not been conducted, the current report on cost distribution of common medical services may be used as basic data in policy-making processes. In addition, the detailed frequency analysis data of individual medical service use may prove useful for practitioners and researchers engaging in real-world practice and related studies.
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